Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVV.L Regulatory News (AVV)

  • There is currently no data for AVV

Form 8.3 - AVEVA GROUP PLC

19 Dec 2022 13:24

RNS Number : 2020K
Barclays PLC
19 December 2022
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

AVEVA GROUP PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Dec 2022

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

3 5/9p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

2,297,892

0.76%

1,935,375

0.64%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

1,955,844

0.65%

1,784,660

0.59%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

4,253,736

1.41%

3,720,035

1.23%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

3 5/9p ordinary

Purchase

125

32.0950 GBP

3 5/9p ordinary

Purchase

246

32.1000 GBP

3 5/9p ordinary

Purchase

330

32.0841 GBP

3 5/9p ordinary

Purchase

408

32.0804 GBP

3 5/9p ordinary

Purchase

1,474

32.1010 GBP

3 5/9p ordinary

Purchase

1,560

32.0844 GBP

3 5/9p ordinary

Purchase

1,623

32.0898 GBP

3 5/9p ordinary

Purchase

1,666

32.0833 GBP

3 5/9p ordinary

Purchase

2,692

32.0900 GBP

3 5/9p ordinary

Purchase

5,000

32.0958 GBP

3 5/9p ordinary

Purchase

5,158

32.0800 GBP

3 5/9p ordinary

Purchase

6,787

32.0964 GBP

3 5/9p ordinary

Purchase

7,817

32.0803 GBP

3 5/9p ordinary

Purchase

14,288

32.0786 GBP

3 5/9p ordinary

Purchase

37,981

32.0850 GBP

3 5/9p ordinary

Sale

40

32.0897 GBP

3 5/9p ordinary

Sale

97

32.1300 GBP

3 5/9p ordinary

Sale

102

32.0700 GBP

3 5/9p ordinary

Sale

146

32.0946 GBP

3 5/9p ordinary

Sale

199

32.0950 GBP

3 5/9p ordinary

Sale

208

32.0848 GBP

3 5/9p ordinary

Sale

309

32.0999 GBP

3 5/9p ordinary

Sale

316

32.1000 GBP

3 5/9p ordinary

Sale

319

32.1030 GBP

3 5/9p ordinary

Sale

376

32.0909 GBP

3 5/9p ordinary

Sale

586

32.0920 GBP

3 5/9p ordinary

Sale

918

32.0825 GBP

3 5/9p ordinary

Sale

1,962

32.0811 GBP

3 5/9p ordinary

Sale

3,094

32.0807 GBP

3 5/9p ordinary

Sale

3,884

32.0855 GBP

3 5/9p ordinary

Sale

4,000

32.0936 GBP

3 5/9p ordinary

Sale

5,504

32.0836 GBP

3 5/9p ordinary

Sale

13,143

32.0872 GBP

3 5/9p ordinary

Sale

24,413

32.0900 GBP

3 5/9p ordinary

Sale

57,402

32.0800 GBP

3 5/9p ordinary

Sale

82,751

32.0801 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

3 5/9p ordinary

SWAP

Long

5

32.0900 GBP

3 5/9p ordinary

SWAP

Long

19

32.0950 GBP

3 5/9p ordinary

SWAP

Long

26

32.0850 GBP

3 5/9p ordinary

CFD

Long

60

32.1375 GBP

3 5/9p ordinary

SWAP

Long

90

32.0821 GBP

3 5/9p ordinary

SWAP

Long

851

32.0928 GBP

3 5/9p ordinary

SWAP

Long

2,086

32.0800 GBP

3 5/9p ordinary

SWAP

Long

4,000

32.0936 GBP

3 5/9p ordinary

SWAP

Long

4,186

32.0814 GBP

3 5/9p ordinary

SWAP

Long

22,433

32.0808 GBP

3 5/9p ordinary

SWAP

Long

35,352

32.0801 GBP

3 5/9p ordinary

SWAP

Long

36,016

32.0807 GBP

3 5/9p ordinary

CFD

Short

1

32.0800 GBP

3 5/9p ordinary

SWAP

Short

2

32.1400 GBP

3 5/9p ordinary

SWAP

Short

9

32.1000 GBP

3 5/9p ordinary

CFD

Short

60

32.0825 GBP

3 5/9p ordinary

SWAP

Short

118

32.0900 GBP

3 5/9p ordinary

SWAP

Short

125

32.0950 GBP

3 5/9p ordinary

SWAP

Short

286

32.0912 GBP

3 5/9p ordinary

SWAP

Short

487

32.0904 GBP

3 5/9p ordinary

SWAP

Short

640

32.0860 GBP

3 5/9p ordinary

CFD

Short

652

32.0824 GBP

3 5/9p ordinary

SWAP

Short

803

32.0858 GBP

3 5/9p ordinary

SWAP

Short

915

32.0800 GBP

3 5/9p ordinary

SWAP

Short

2,000

32.1018 GBP

3 5/9p ordinary

SWAP

Short

3,000

32.0918 GBP

3 5/9p ordinary

CFD

Short

6,787

32.0964 GBP

3 5/9p ordinary

SWAP

Short

37,380

32.0855 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

19 Dec 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETGPGPPPUPPGWB
Date   Source Headline
28th Oct 20229:58 amEQSDirector/PDMR Shareholding
28th Oct 20229:19 amRNSForm 8.5 (EPT/RI) - Aveva Group plc
28th Oct 20228:36 amRNSForm 8.5 (EPT/RI)
28th Oct 20227:00 amRNSForm 8.3 - AVEVA Group plc
27th Oct 20224:15 pmRNSForm 8.5 (EPT/RI) - AVEVA Group plc Amend
27th Oct 20224:15 pmRNSForm 8.5 (EPT/RI) - AVEVA Group plc Amend
27th Oct 20224:14 pmRNSForm 8.5 (EPT/RI) - AVEVA Group plc Amend
27th Oct 20223:20 pmRNSForm 8.3 - AVEVA Group plc
27th Oct 20222:32 pmRNSForm 8.3 - Aveva Group PLC
27th Oct 20221:22 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
27th Oct 202211:53 amRNSForm 8.3 - AVEVA Group plc
27th Oct 202211:43 amRNSForm 8.3 - AVEVA Group plc
27th Oct 202211:40 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
27th Oct 202211:34 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
27th Oct 202211:17 amRNSForm 8.3 - AVEVA Group plc
27th Oct 202211:03 amRNSForm 8.3 - Aveva Group Plc
27th Oct 20228:56 amRNSForm 8.5 (EPT/RI) - Aveva Group plc
27th Oct 20228:32 amRNSForm 8.5 (EPT/RI)
27th Oct 20227:00 amRNSForm 8.3 - AVEVA Group plc
26th Oct 20223:50 pmRNSForm 8.3 - AVEVA Group PLC
26th Oct 20223:20 pmRNSForm 8.3 - AVEVA Group plc
26th Oct 20222:09 pmRNSRule 2.9 Announcement
26th Oct 20221:10 pmRNSForm 8.3 - AVEVA Group plc
26th Oct 20221:09 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
26th Oct 202212:55 pmRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc Amend
26th Oct 202212:47 pmRNSForm 8.3 - AVEVA Group plc
26th Oct 202210:55 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
26th Oct 202210:47 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
26th Oct 20229:59 amRNSForm 8.3 - Aveva Group Plc
26th Oct 20229:23 amRNSForm 8.3 - AVEVA Group plc
26th Oct 20228:42 amRNSForm 8.5 (EPT/RI) - Aveva Group plc
26th Oct 20228:35 amRNSForm 8.5 (EPT/RI)
25th Oct 20224:44 pmRNSRule 2.9 Announcement
25th Oct 20223:34 pmRNSForm 8.3 - AVEVA Group PLC
25th Oct 20223:20 pmRNSForm 8.3 - AVEVA Group plc
25th Oct 20222:06 pmRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
25th Oct 20222:01 pmRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
25th Oct 20221:46 pmRNSForm 8.3 - AVEVA Group plc
25th Oct 20221:42 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
25th Oct 202210:41 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
25th Oct 202210:34 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
25th Oct 202210:14 amRNSForm 8.3 - AVEVA Group plc
25th Oct 20229:11 amRNSForm 8.3 - Aveva Group Plc
25th Oct 20228:47 amRNSForm 8.5 (EPT/RI) - Aveva Group plc
25th Oct 20228:29 amRNSForm 8.5 (EPT/RI)
24th Oct 20223:20 pmRNSForm 8.3 - AVEVA Group plc
24th Oct 20222:12 pmBUSForm 8.3 - AVEVA Group plc
24th Oct 20222:08 pmRNSForm 8.3 - Aveva Group PLC
24th Oct 20221:44 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
24th Oct 202211:57 amRNSForm 8.3 - AVEVA Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.